Regeneron Pharmaceuticals (REGN) Change in Inventory (2013 - 2026)

Regeneron Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at -$26.6 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 117.47% year-over-year to -$26.6 million; the TTM figure through Mar 2026 stood at $96.4 million (down 84.36% YoY), while the FY2025 annual figure was $275.3 million, down 55.58% from the prior year.
• Change in Inventory was -$26.6 million for Q1 2026 at Regeneron Pharmaceuticals, down from -$2.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $240.1 million in Q2 2022 to a low of -$26.6 million in Q1 2026.
• Historically, Change in Inventory has averaged $108.0 million across 5 years, with a median of $100.4 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Change in Inventory soared 867.09% in 2022, then plunged 117.47% in 2026.
• A 5-year view of Change in Inventory shows it stood at $144.3 million in 2022, then tumbled by 67.22% to $47.3 million in 2023, then jumped by 148.84% to $117.7 million in 2024, then sank by 101.78% to -$2.1 million in 2025, then slumped by 1166.67% to -$26.6 million in 2026.
• The last three Change in Inventory figures came in at -$26.6 million (Q1 2026), -$2.1 million (Q4 2025), and $82.6 million (Q3 2025), per Business Quant data.